Craft Beer, COVID, and Distilleries

August 11, 2020
150320221647327583

PRI brings together distillery owners, craft brewers, and licensing experts to examine the impact that COVID-19 has had on the production of our favorite cocktails and beers.

 

Tuesday, August 11, 2020
11am Pacific Time

 

Panel:

Jarrett Dieterle, Director of Commercial Freedom and Senior Fellow, R Street Institute
Cris Steller, Dry Diggings Distillery, El Dorado Hills, CA
Daniel Moffatt Co-Owner and Head Brewer, Fountainhead Brewing Company, Sacramento, CA
 

The coronavirus pandemic continues to wreak havoc on the American economy. The craft beer and distillery industry is one that has seen incredible disruption, with states and counties opening and closing breweries almost overnight. California, like many other states, has adjusted its alcohol distribution and regulations to allow breweries and distilleries easier access to customers. Are these regulations working? Are there any changes needed? What does the rest of 2020 look like?  Should temporary regulatory relief be made permanent?
 

We will discuss these topics and more with a distillery owner, craft brewer, and subject matter expert on federal alcohol regulations. You’ll hear how breweries and distilleries are adapting and surviving in one of the most trying economic times in modern history straight from the source (or tap).

We will also talk about how regulatory changes have helped or hurt distilleries and breweries, and what steps can be taken to ensure the industry survives the uncertainty of the coronavirus pandemic.


(function(d, s) {
var js, el = d.getElementsByTagName(s)[0];
window.BB_REG_FORM_ID = “71f98626-06b4-4fc4-a77f-269104ac0b84”;
window.BB_REG_FORM_ENVIRONMENT_ID = “p-VFwaa-F3ZU6uSLzlD1sBnw”;
js = d.createElement(s);
js.src = “https://sky.blackbaudcdn.net/skyuxapps/registration-form/assets/online_registrations_form_loader_v1.f8744b9a2e1826070a839886cbb55c9de563274d.js”;
el.parentNode.insertBefore(js, el);
})(document, “script”);

Tell Your Friends

Related

Medicare’s Drug Price Controls Could Actually Raise Prices In The Long Run

Four years ago, on August 16, President Biden signed the Inflation Reduction Act into law. Lawmakers promised that letting Medicare set drug prices would save ...
2972666940 c0090fdf80 JimmyEmersono (1)

After union flex, Folsom squelches plan to eye privatization

After union flex, Folsom squelches plan to eye privatization By Sal Rodriguez | August 11, 2026 Fiscal challenges — from diminishing revenues to rising expenses ...

A not so Brightline: California’s other bullet train boondoggle

It’s happening. This time, it’s really happening. That’s what dignitaries at the pseudo-event told themselves on April 22, 2024 — the day Brightline West “officially ...
Scroll to Top